Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alpha-Omega Labs is an alternative medicine company best known for its controversial "Cansema" (Black Salve) products, which it markets as treatments for various forms of cancer. Founded by Greg Caton in 1990, the company has faced significant legal challenges from the U.S. Food and Drug Administration (FDA) for selling unapproved and misbranded drugs. Following a 2003 raid and the subsequent imprisonment of its founder, the company relocated its operations to Ecuador, where it continues to manufacture and distribute herbal supplements and topical treatments globally via the internet. Its product line includes escharotics, herbal tinctures, and various "natural" health remedies that are not recognized as standard medical treatments by mainstream oncology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alpha-Omega Labs.